Abstract
OBJECTIVE
To explore whether intrathecal baclofen (ITB) therapy improves ambulation in stroke survivors.
SETTING
Tertiary care center.
PARTICIPANTS
Ten adults with poststroke hemiparesis who were ambulatory at the time of pump implantation.
INTERVENTIONS
Implantation of ITB pump after inadequate control of spasticity with other interventions. Time from stroke onset to implantation averaged 28.6 months (range, 9-55mo).
MAIN OUTCOME MEASURES
Customary walking speed was measured from the time required to walk 50ft (15m) at a self-selected pace. Evaluators rated spastic hypertonia and functional mobility.
RESULTS
Statistically significant improvements occurred in walking speed, functional mobility ratings, and spasticity (P<.05) at a follow-up interval that averaged 8.9 months. Mean walking speed over 50ft improved from 36.6 to 52cm/s. Mean Modified Ashworth Scale scores in the muscles of the affected lower limb improved from 2.0 to 0.4. Normal muscle strength (5/5) was preserved in the unaffected limbs.
CONCLUSIONS
This preliminary study suggests that ITB therapy, in combination with physical therapy, may improve walking speed and functional mobility in ambulatory individuals with poststroke spastic hemiplegia.
TY - JOUR
T1 - Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study.
AU - Francisco,Gerard E,
AU - Boake,Corwin,
PY - 2003/8/15/pubmed
PY - 2003/9/10/medline
PY - 2003/8/15/entrez
SP - 1194
EP - 9
JF - Archives of physical medicine and rehabilitation
JO - Arch Phys Med Rehabil
VL - 84
IS - 8
N2 - OBJECTIVE: To explore whether intrathecal baclofen (ITB) therapy improves ambulation in stroke survivors. DESIGN: Case series. SETTING: Tertiary care center. PARTICIPANTS: Ten adults with poststroke hemiparesis who were ambulatory at the time of pump implantation. INTERVENTIONS: Implantation of ITB pump after inadequate control of spasticity with other interventions. Time from stroke onset to implantation averaged 28.6 months (range, 9-55mo). MAIN OUTCOME MEASURES: Customary walking speed was measured from the time required to walk 50ft (15m) at a self-selected pace. Evaluators rated spastic hypertonia and functional mobility. RESULTS: Statistically significant improvements occurred in walking speed, functional mobility ratings, and spasticity (P<.05) at a follow-up interval that averaged 8.9 months. Mean walking speed over 50ft improved from 36.6 to 52cm/s. Mean Modified Ashworth Scale scores in the muscles of the affected lower limb improved from 2.0 to 0.4. Normal muscle strength (5/5) was preserved in the unaffected limbs. CONCLUSIONS: This preliminary study suggests that ITB therapy, in combination with physical therapy, may improve walking speed and functional mobility in ambulatory individuals with poststroke spastic hemiplegia.
SN - 0003-9993
UR - https://www.unboundmedicine.com/medline/citation/12917859/Improvement_in_walking_speed_in_poststroke_spastic_hemiplegia_after_intrathecal_baclofen_therapy:_a_preliminary_study_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0003-9993(03)00134-5
DB - PRIME
DP - Unbound Medicine
ER -